A new blood test that measures donor-derived cell-free DNA (dd-cfDNA) is reshaping post-transplant surveillance by offering clinical laboratories a powerful, noninvasive tool to detect organ injury earlier than traditional methods.
For the full article click here: Clinical Labs Gain Ground with Noninvasive dd-cfDNA Transplant Surveillance